Skip to Main Content
Contact Us
Category: Press Release
Catalyst Clinical Research Earns Recognition from Inc. Magazine as one of its Best Places to Work for 2022 This is the company’s first year on Inc.’s coveted list and had the additional honor Read Now Catalyst Clinical Research Acquires Aptus Clinical Aptus Helps Accelerate European Expansion, Broaden Client Services, and Enhance Patient Impact The transaction capitalizes Read Now Catalyst and Aptus Join Forces of May the 4th Catalyst Clinical Research Acquires Aptus Clinical to Accelerate European Expansion, Broaden Client Services, and Enhance Patient Impact The transaction capitalizes on the two company’s combined geographic strengths, complementary service offerings and therapeutic Read Now Catalyst Names Niklas Morton as First Chief Operating Officer Veteran Biotech Executive Will Direct Operations, Help Shape Growth Strategy  Wilmington, NC, 5 April 2022 Read Now A patient's vital signs are displayed on a bedside monitor. Development of Novel Wearables and AI Capabilities to Support the Monitoring of COVID-19 Patients As the COVID-19 pandemic developed, it soon emerged that hospital staff faced significant challenges in Read Now Catalyst Clinical Research, Ledger Run Expand Strategic Partnership To Accelerate Research, Streamline Clinical Operations Catalyst Streamlines Business Processes with New Technologies Wilmington, NC and Tiburon, CA – 8 February Read Now Catalyst CEO Nick Dyer Named to 2021 “Wilmington Biz 100,” Described as Community Innovator Wilmington Business Publication Highlights Accomplishments of Regional Leaders Wilmington, NC, 8 December 2021 – Catalyst Read Now Veteran Biopharma and CRO Executive Marshall Skelton Joins Catalyst New Role as Senior Vice President of People and Culture Wilmington, NC, 15 November 2021 Read Now For Second Consecutive Year, Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle The Triangle Business Journal’s “Fast 50” List Salutes High-Growth, Privately Owned Companies Raleigh, NC, 2 Read Now Woman at computer looking at screen with colleagues next to her. CRO Support for XRad Therapeutics XRad Therapeutics announced first patient dosed in Phase 1a clinical trial of XRD-0394 for metastatic, Read Now